Cited by 63Bipolar Disorder and TreatmentTryptophan and brain disordersTreatment of Major Depression

IL-23 and TGF-β1 levels as potential predictive biomarkers in treatment of bipolar I disorder with acute manic episode

Li, Haozhe, Hong, Wu, Zhang, Chen, Wu, Zhiguo, Wang, Zuowei, Yuan, Chenmei, Li, Zezhi, Huang, Jia +2 more·2015·Journal of Affective Disorders

Abstract

Background Growing evidence suggests that immune dysfunction may be involved in the physiopathology of bipolar disorders, with typical first-line treatment using lithium and quetiapine serving to restore pro-inflammation status. This study aimed to explore the relationship between inflammatory cytokines-especially regulatory factors and the effect of combination treatment-with quetiapine and lithium in manic patients. Methods 41 patients of bipolar I disorder with manic episode were enrolled and received combination treatment with quetiapine and lithium. Blood sampling and assessments were performed at baseline and after 8-week treatment. YMRS was used to evaluate the severity of manic symptoms at the same time of detecting plasma levels. A control group comprised of 36 age and gender matched healthy volunteers were enrolled, and their blood samples were assessed at the time of enrollment. Results TGF-β1 and IL-23 plasma levels in patients were significantly higher than healthy controls at baseline (P Limitations The relatively small sample size in patients and control groups should be considered as a limitation of the study. Conclusions The high initial plasma level of TGF-β1 and low initial plasma level of IL-23 indicated better prognosis during combination treatment with quetiapine and lithium in manic patients. The trend of decreasing plasma levels of TNF-α, TGF-β1, IL-23 and IL-17 indicated therapeutic effect.

Integrity signals

Registry

Crossref · 10.1016/j.jad.2014.12.033

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Li, H., Hong, W., Zhang, C., Wu, Z., Wang, Z., Yuan, C., Li, Z., Huang, J., Lin, Z., & Fang, Y.
Affiliations
  • Shanghai Jiao Tong University (CN)
  • Second Military Medical University (CN)
Venue
Journal of Affective Disorders
Publisher
Elsevier BV
Published
2015-03
Volume
174
Pages
361-366
ISSN
0165-0327 (ISSN-L)
OpenAlex
W2016121778
Cited by
63
References
8
Citations by year
2026: 1 · 2025: 4 · 2024: 7 · 2022: 8 · 2021: 3 · 2020: 5 · 2019: 10 · 2018: 6 · 2017: 6 · 2016: 8 · 2015: 5
FWCI
4.84
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Affective Disorders (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
bipolar I disorder, manic episodes, IL-23, TGF-β1, inflammatory cytokines, predictive biomarkers, quetiapine, lithium, TNF-α, IL-17, treatment response, immune dysfunction
MeSH terms
Quetiapine Fumarate, Adult, Bipolar Disorder, Dibenzothiazepines, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Severity of Illness Index, Antipsychotic Agents, Tumor Necrosis Factor-alpha, Biomarkers, Case-Control Studies, Lithium Compounds, Interleukin-17, Interleukin-23, Transforming Growth Factor beta1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review